Flow Cytometry Market by Technology (Cell-based, Bead-based), Product & Service (Analyzer, Sorter, Consumables, Software), Application ((Research - Immunology, Stem cell), (Clinical - Hematology)), End User & Region - Global Forecast to 2028
Report Code: BT 6015 Aug, 2023, by marketsandmarkets.com
The global flow cytometry market in terms of revenue was estimated to be worth $4.7 billion in 2023 and is poised to reach $7.0 billion by 2028, growing at a CAGR of 8.3% from 2023 to 2028. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market. The rising prevalence of HIV/AIDS and cancer, increasing adoption of flow cytometry in clinical applications, and launch of technological flow cytometry instruments and consumables are driving market growth. However, the high cost of instruments is a major factor likely to hamper the growth of the market.
Attractive Opportunities in the Flow Cytometry Market
To know about the assumptions considered for the study, Request for Free Sample Report
Flow Cytometry Market Dynamics
DRIVER: Technological advancements in flow cytometry instruments
Key players operating in the global market are increasingly focused on developing and commercializing technologically advanced flow cytometry products that offer streamlined workflows, ease of operability, and improved turnaround times. This results in the development of affordable, innovative, compact, and easy-to-use flow cytometry instruments. Such innovative products serve as significant driving factors during the forecast period, especially in mature markets where the adoption rate of technologically advanced products is high.
RESTRAINT: High product pricing
Most end users, such as clinical laboratories, large research facilities, and pharmaceutical companies, require many flow cytometry instruments simultaneously to carry out multiple research studies. This may lead to a significant increase in the expenditure cost associated with the procurement and maintenance of such devices. Along with this, the maintenance costs and several other indirect expenses result in an overall increase in the total cost of ownership of these instruments. Increased product installation costs and expenditures hinder the optimal adoption of flow cytometry instruments in the area of clinical and research applications, particularly in developing nations. It has been observed that flow cytometry-based cell sorters are more expensive than cell analyzers; thus, increased costs will ultimately restrain the market.
OPPORTUNITY: Public-private funding initiatives in stem cell research
Flow cytometry enables researchers to obtain population-based statistics and multiparametric data on differentiating stem cell cultures. This technique allows them to isolate stem cells using multiple fluorescent-labeled antibodies. In addition to the supportive regulatory environment in emerging countries, many stem cell products are in pipelines, and their wide range of application in treating various diseases lead to an increase in research activities globally and are provided with financial support by public-private organizations in the stem cell research industry.
CHALLENGE: Shortage of skilled professionals
Flow cytometers require expertise with relevant experience and technological knowledge. Users of flow cytometry platforms must know about the different control parameters, the range of available fluorescent-labeled compounds, protocols, commonly used reagents, and specific data analysis solutions. Flow cytometry-based techniques largely depend on the operator’s analytical process flow, including pipetting volume, sample integrity, and incubation time. Advanced and highly complex flow cytometers generate a wide array of data outputs that require reviewing expertise, and the absence of such expertise among researchers and clinicians may limit the adoption of novel instruments, ultimately serving as a challenge for the flow cytometry industry.
Flow Cytometry Market Ecosystem
The ecosystem of the market is a dynamic network of various stakeholders, technologies, products, and services that collectively support the research, development, and application of flow cytometry in diverse fields. This ecosystem enables the advancement of scientific knowledge, diagnostics, and therapeutic discoveries.
Prominent players in the global flow cytometry market are BD (US), Danaher Corporation (US), Thermo Fisher Scientific, Inc. (US), Agilent Technologies, Inc. (US), Bio-Rad Laboratories, Inc. (US), and others.
The reagents & consumables segment dominated the flow cytometry industry in 2022.
Based on product & service, the flow cytometry market is segmented into services, software, reagents & consumables, instruments, and accessories. The reagents & consumables segment dominated the process segment in 2022. The development of high-quality reagents and the launch of application-specific reagents, coupled with the increasing number of analytical procedures, are some of the factors driving segmental growth.
The academic & research institutes segment accounted for the end user segment dominated the flow cytometry industry in 2022.
Based on end user, the flow cytometry market is segmented into hospitals & clinical testing laboratories, academic & research institutes, and pharmaceutical & biotechnology companies. The academic & research institutes segment dominated the process segment in 2022. The growing use of flow cytometry studies for various research activities (such as cancer, stem cell, and HIV), an increasing number of cancer and stem cell research projects globally, and rising public-private funding for research are likely to project market growth. Furthermore, the increasing number of contract research organizations (CROs) providing drug discovery services and recent mergers & acquisitions are likely to contribute to the growth of the segment.
North America held a dominant share in the regional market for the flow cytometry industry in 2022.
To know about the assumptions considered for the study, download the pdf brochure
Geographically, the flow cytometry market markets are segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. In 2022, North America accounted for the largest share of the market, followed by Europe & Asia Pacific. The region's dominant position can be attributed to several key factors, such as the presence of a favorable business environment, growing government support through funds and grants, high prevalence of HIV/AIDS and cancer, growing focus on the development of treatment options for target diseases (such as cancer and immunological disorders), and the strong presence of key players.
Key players in the flow cytometry market include BD (US), Danaher Corporation (US), Thermo Fisher Scientific, Inc. (US), Agilent Technologies, Inc. (US), Sony Corporation (Japan), Bio-Rad Laboratories, Inc. (US) and among others.
Scope of the Flow Cytometry Industry
|
Report Metric |
Details |
|
Market Revenue in 2023 |
$4.7 billion |
|
Projected Revenue by 2028 |
$7.0 billion |
|
Revenue Rate |
Poised to Grow at a CAGR of 8.3% |
|
Market Driver |
Technological advancements in flow cytometry instruments |
|
Market Opportunity |
Public-private funding initiatives in stem cell research |
This report categorizes the Flow Cytometry market to forecast revenue and analyze trends in each of the following submarkets:
By Technology
- Cell-based Flow Cytometry
- Bead-based Flow Cytometry
By Product and Service
- Reagents and Consumables
-
Instruments
-
Cell Analyzers
- High-range
- Mid-range
- Low-range
-
Cell Sorters
- High-range
- Mid-range
- Low-range
-
Cell Analyzers
- Services
- Software
- Accessories
By Application
-
Research Applications
-
Pharmaceuticals and Biotechnology
- Drug Discovery
- Stem Cell Research
- In Vitro Toxicity Testing
- Immunology
- Cell Sorting
- Apoptosis
- Cell Cycle Analysis
- Cell Viability
- Cell Counting
- Other Research Applications
-
Pharmaceuticals and Biotechnology
-
Clinical Applications
- Cancer Diagnostics
- Hematology
- Autoimmune Diseases
- Organ Transplantation
- Other Clinical Applications
- Industrial Applications
By End User
- Academic & Research Institutes
- Hospitals & Clinical Testing Laboratories
- Pharmaceutical & Biotechnology Companies
By Region
-
North America
- US
- Canada
-
Europe
- Germany
- France
- Italy
- Spain
- UK
- Rest of Europe
-
Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Singapore
- Indonesia
- Rest of Asia Pacific
-
Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
Recent Developments of Flow Cytometry Industry
- In June 2023, BD launched The BD FACSDuet Premium Sample Preparation System to automate sample preparation in clinical flow cytometry diagnostics.
- In May 2023, Sysmex launched Clinical Flow Cytometry System Flow Cytometer XF-1600, Sample Preparation System PS-10, antibody reagents, and other related products in Japan.
- In June 2022, BD (US) launched BD FACSDiscover S8 Cell Sorter with high-speed imaging technology that sorts cells based on visual characteristics.
- In March 2022, Beckman Coulter, Inc. (US) launched a fully automated sample preparation system (SPS) CellMek SPS, which offers on-demand processing for many sample types to help laboratories expand their capabilities.
Frequently Asked Questions (FAQ):
What is the projected market revenue value of the global flow cytometry market?
The global flow cytometry market boasts a total revenue value of $7.0 billion by 2028.
What is the estimated growth rate (CAGR) of the global flow cytometry market?
The global flow cytometry market has an estimated compound annual growth rate (CAGR) of 8.3% and a revenue size in the region of $4.7 billion in 2023.
To speak to our analyst for a discussion on the above findings, click Speak to Analyst
TABLE OF CONTENTS
1 INTRODUCTION (Page No. - 55)
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS AND EXCLUSIONS
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.3.2 YEARS CONSIDERED
1.4 CURRENCY CONSIDERED
1.5 RESEARCH LIMITATIONS
1.6 STAKEHOLDERS
1.7 SUMMARY OF CHANGES
1.8 RECESSION IMPACT
2 RESEARCH METHODOLOGY (Page No. - 60)
2.1 RESEARCH DATA
FIGURE 1 RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.2 PRIMARY DATA
FIGURE 2 FLOW CYTOMETRY MARKET: BREAKDOWN OF PRIMARIES
2.2 MARKET SIZE ESTIMATION
FIGURE 3 FLOW CYTOMETRY INDUSTRY: MARKET SIZE ESTIMATION FOR SUPPLY SIDE ANALYSIS (2022)
FIGURE 4 MARKET SIZE ESTIMATION: APPROACH 1 (REVENUE SHARE ANALYSIS) FOR 2022
FIGURE 5 ILLUSTRATIVE EXAMPLE OF BD: REVENUE SHARE ANALYSIS (2022)
2.2.1 PRIMARY INSIGHTS
FIGURE 6 MARKET VALIDATION FROM PRIMARY EXPERTS
2.2.2 MARKET SIZE ESTIMATION METHODOLOGY
FIGURE 7 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
2.3 GROWTH RATE ASSUMPTIONS
FIGURE 8 MARKET: CAGR PROJECTIONS DURING FORECAST PERIOD
FIGURE 9 MARKET: GROWTH ANALYSIS OF DRIVERS, RESTRAINTS, CHALLENGES, AND OPPORTUNITIES
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION
FIGURE 10 DATA TRIANGULATION METHODOLOGY
2.5 STUDY ASSUMPTIONS
2.6 RISK ANALYSIS
2.7 RECESSION IMPACT ANALYSIS
TABLE 1 GLOBAL INFLATION RATE PROJECTION, 2024–2028 (% GROWTH)
TABLE 2 US HEALTH EXPENDITURE, 2019–2022 (USD MILLION)
TABLE 3 US HEALTH EXPENDITURE, 2023–2027 (USD MILLION)
3 EXECUTIVE SUMMARY (Page No. - 72)
FIGURE 11 FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2023 VS. 2028 (USD MILLION)
FIGURE 12 FLOW CYTOMETRY INDUSTRY, BY PRODUCT & SERVICE, 2023 VS. 2028 (USD MILLION)
FIGURE 13 MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION)
FIGURE 14 MARKET, BY END USER, 2023 VS. 2028 (USD MILLION)
FIGURE 15 GEOGRAPHICAL SNAPSHOT OF MARKET
4 PREMIUM INSIGHTS (Page No. - 76)
4.1 FLOW CYTOMETRY MARKET OVERVIEW
FIGURE 16 RISING NEED FOR RESEARCH APPLICATIONS IN DRUG DISCOVERY & DEVELOPMENT TO DRIVE MARKET
4.2 NORTH AMERICA: FLOW CYTOMETRY INDUSTRY, BY PRODUCT & SERVICE AND COUNTRY
FIGURE 17 REAGENTS & CONSUMABLES SEGMENT IN US ACCOUNTED FOR LARGEST MARKET SHARE IN 2022
4.3 MARKET SHARE, BY TECHNOLOGY, 2023 VS. 2028
FIGURE 18 CELL-BASED FLOW CYTOMETRY SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD
4.4 MARKET SHARE, BY END USER
FIGURE 19 ACADEMIC & RESEARCH INSTITUTES SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN 2022
4.5 MARKET: GEOGRAPHICAL GROWTH OPPORTUNITIES
FIGURE 20 CHINA PROJECTED TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD
5 MARKET OVERVIEW (Page No. - 80)
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 21 FLOW CYTOMETRY MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.2.1 DRIVERS
5.2.1.1 Rising incidence of HIV/AIDS and cancer
TABLE 4 INCIDENCE OF HIV/AIDS, BY REGION (2022)
TABLE 5 GLOBAL CANCER INCIDENCE, 2020 VS. 2040
5.2.1.2 Wide applications in research for drug discovery & development
5.2.1.3 Use of flow cytometry in regenerative medicine
5.2.1.4 Growing public-private initiatives in immunology and immuno-oncology research
5.2.1.5 Technological advancements in flow cytometry instruments
TABLE 6 KEY TECHNOLOGICAL ADVANCEMENTS (2019–2022)
5.2.2 RESTRAINTS
5.2.2.1 High product pricing
5.2.3 OPPORTUNITIES
5.2.3.1 High growth potential in emerging economies
5.2.3.2 Rising focus on stem cell research
TABLE 7 ESTIMATED EXPENDITURE BY NIH FOR STEM CELL RESEARCH (2019−2024)
5.2.3.3 Uptake of recombinant DNA technology for antibody production
5.2.4 CHALLENGES
5.2.4.1 Complexities related to reagent development
5.2.4.2 Shortage of skilled professionals
5.3 SUPPLY CHAIN ANALYSIS
FIGURE 22 DIRECT DISTRIBUTION STRATEGY PREFERRED BY PROMINENT COMPANIES
5.4 VALUE CHAIN ANALYSIS
FIGURE 23 MARKET: VALUE CHAIN ANALYSIS
5.5 ECOSYSTEM ANALYSIS
FIGURE 24 MARKET: ECOSYSTEM MAP
5.5.1 ECOSYSTEM ROLE
5.6 REGULATORY ASSESSMENT
5.6.1 STRINGENT FDA REQUIREMENTS
5.6.2 ANALYTE-SPECIFIC REAGENT RULE
5.6.3 LIMITATIONS IN VALIDATION PROTOCOLS FOR CELL-BASED ASSAYS
5.6.4 ABSENCE OF GUIDELINES ON CELL-BASED FLUORESCENCE ASSAYS
5.6.5 IVD CE MARK APPROVALS
5.6.6 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 8 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.6.7 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 9 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER BODIES
5.6.8 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 10 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.6.9 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 11 LATIN AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.6.10 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 12 MIDDLE EAST & AFRICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.7 PORTER’S FIVE FORCES ANALYSIS
TABLE 13 MARKET: PORTER’S FIVE FORCES ANALYSIS
5.7.1 INTENSITY OF COMPETITIVE RIVALRY
5.7.2 BARGAINING POWER OF SUPPLIERS
5.7.3 BARGAINING POWER OF BUYERS
5.7.4 THREAT OF SUBSTITUTES
5.7.5 THREAT OF NEW ENTRANTS
5.8 PATENT ANALYSIS
5.8.1 LIST OF MAJOR PATENTS
5.9 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
FIGURE 25 RISING USE OF FLOW CYTOMETRY IN CLINICAL APPLICATIONS TO DRIVE MARKET
5.10 PRICING ANALYSIS
5.10.1 AVERAGE SELLING PRICE OF FLOW CYTOMETERS, BY TYPE
TABLE 14 COST OF FLOW CYTOMETERS, BY TYPE
5.10.2 COST OF FLOW CYTOMETERS AND OTHER PRODUCTS, BY KEY PLAYERS
TABLE 15 COST OF FLOW CYTOMETERS AND OTHER PRODUCTS, BY KEY PLAYERS
5.10.3 COST OF FLOW CYTOMETRY SOFTWARE
5.10.4 AVERAGE SELLING PRICE FOR FLOW CYTOMETRY INSTRUMENTS
5.11 KEY CONFERENCES AND EVENTS
TABLE 16 MARKET: DETAILED LIST OF CONFERENCES AND EVENTS (2023-2024)
5.12 TRADE DATA
TABLE 17 IMPORT DATA FOR FLOW CYTOMETERS, BY COUNTRY, 2017-2021 (USD THOUSAND)
TABLE 18 EXPORT DATA FOR FLOW CYTOMETERS, BY COUNTRY, 2017–2021 (USD THOUSAND)
TABLE 19 IMPORT DATA FOR FLOW CYTOMETERS, BY COUNTRY, 2022 (USD THOUSAND)
TABLE 20 EXPORT DATA FOR FLOW CYTOMETERS, BY COUNTRY, 2022 (USD THOUSAND)
5.13 KEY STAKEHOLDERS AND BUYING CRITERIA
FIGURE 26 KEY STAKEHOLDERS IN BUYING PROCESS
FIGURE 27 KEY BUYING CRITERIA FOR FLOW CYTOMETRY PRODUCTS AMONG END USERS
6 FLOW CYTOMETRY MARKET, BY TECHNOLOGY (Page No. - 110)
6.1 INTRODUCTION
TABLE 21 FLOW CYTOMETRY INDUSTRY, BY TECHNOLOGY, 2021–2028 (USD MILLION)
6.2 CELL-BASED FLOW CYTOMETRY
6.2.1 RISING R&D INVESTMENTS FOR NEW THERAPEUTIC AGENTS TO DRIVE MARKET
TABLE 22 MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 23 NORTH AMERICA: MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 24 EUROPE: MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 25 ASIA PACIFIC: MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 26 LATIN AMERICA: MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
6.3 BEAD-BASED FLOW CYTOMETRY
6.3.1 ABILITY TO OFFER HIGH RELIABILITY AND CONSISTENT MEASUREMENT TO SUPPORT MARKET GROWTH
FIGURE 28 MARKET: MARKET SHARE ANALYSIS (2022)
TABLE 27 MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 28 NORTH AMERICA: MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 29 EUROPE: MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 30 ASIA PACIFIC: MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 31 LATIN AMERICA: MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
7 FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE (Page No. - 118)
7.1 INTRODUCTION
TABLE 32 FLOW CYTOMETRY INDUSTRY, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
7.2 REAGENTS & CONSUMABLES
7.2.1 RECURRING REQUIREMENT OF CONSUMABLES AND DEVELOPMENT OF HIGH-QUALITY REAGENTS TO DRIVE MARKET
TABLE 33 MARKET FOR REAGENTS & CONSUMABLES, BY REGION, 2021–2028 (USD MILLION)
TABLE 34 NORTH AMERICA: MARKET FOR REAGENTS & CONSUMABLES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 35 EUROPE: MARKET FOR REAGENTS & CONSUMABLES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 36 ASIA PACIFIC: MARKET FOR REAGENTS & CONSUMABLES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 37 LATIN AMERICA: MARKET FOR REAGENTS & CONSUMABLES, BY COUNTRY, 2021–2028 (USD MILLION)
7.3 INSTRUMENTS
TABLE 38 MARKET FOR INSTRUMENTS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 39 MARKET FOR INSTRUMENTS, BY REGION, 2021–2028 (USD MILLION)
TABLE 40 NORTH AMERICA: MARKET FOR INSTRUMENTS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 41 EUROPE: MARKET FOR INSTRUMENTS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 42 ASIA PACIFIC: MARKET FOR INSTRUMENTS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 43 LATIN AMERICA: MARKET FOR INSTRUMENTS, BY COUNTRY, 2021–2028 (USD MILLION)
7.3.1 CELL ANALYZERS
TABLE 44 MARKET FOR CELL ANALYZERS, BY PRICE RANGE, 2021–2028 (USD MILLION)
TABLE 45 MARKET FOR CELL ANALYZERS, BY REGION, 2021–2028 (USD MILLION)
TABLE 46 NORTH AMERICA: MARKET FOR CELL ANALYZERS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 47 EUROPE: MARKET FOR CELL ANALYZERS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 48 ASIA PACIFIC: MARKET FOR CELL ANALYZERS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 49 LATIN AMERICA: MARKET FOR CELL ANALYZERS, BY COUNTRY, 2021–2028 (USD MILLION)
7.3.1.1 High-range cell analyzers
7.3.1.1.1 Advantages of higher sensitivity and accuracy to drive adoption among end users
TABLE 50 MARKET FOR HIGH-RANGE CELL ANALYZERS, BY REGION, 2021–2028 (USD MILLION)
TABLE 51 NORTH AMERICA: MARKET FOR HIGH-RANGE CELL ANALYZERS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 52 EUROPE: MARKET FOR HIGH-RANGE CELL ANALYZERS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 53 ASIA PACIFIC: MARKET FOR HIGH-RANGE CELL ANALYZERS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 54 LATIN AMERICA: MARKET FOR HIGH-RANGE CELL ANALYZERS, BY COUNTRY, 2021–2028 (USD MILLION)
7.3.1.2 Mid-range cell analyzers
7.3.1.2.1 Availability of compact & high-performance analyzers to support market growth
TABLE 55 MARKET FOR MID-RANGE CELL ANALYZERS, BY REGION, 2021–2028 (USD MILLION)
TABLE 56 NORTH AMERICA: MARKET FOR MID-RANGE CELL ANALYZERS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 57 EUROPE: MARKET FOR MID-RANGE CELL ANALYZERS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 58 ASIA PACIFIC: MARKET FOR MID-RANGE CELL ANALYZERS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 59 LATIN AMERICA: MARKET FOR MID-RANGE CELL ANALYZERS, BY COUNTRY, 2021–2028 (USD MILLION)
7.3.1.3 Low-range cell analyzers
7.3.1.3.1 High adoption among price-sensitive end users to propel market
TABLE 60 MARKET FOR LOW-RANGE CELL ANALYZERS, BY REGION, 2021–2028 (USD MILLION)
TABLE 61 NORTH AMERICA: MARKET FOR LOW-RANGE CELL ANALYZERS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 62 EUROPE: MARKET FOR LOW-RANGE CELL ANALYZERS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 63 ASIA PACIFIC: MARKET FOR LOW-RANGE CELL ANALYZERS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 64 LATIN AMERICA: MARKET FOR LOW-RANGE CELL ANALYZERS, BY COUNTRY, 2021–2028 (USD MILLION)
7.3.2 CELL SORTERS
TABLE 65 MARKET FOR CELL SORTERS, BY PRICE RANGE, 2021–2028 (USD MILLION)
TABLE 66 MARKET FOR CELL SORTERS, BY REGION, 2021–2028 (USD MILLION)
TABLE 67 NORTH AMERICA: MARKET FOR CELL SORTERS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 68 EUROPE: MARKET FOR CELL SORTERS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 69 ASIA PACIFIC: MARKET FOR CELL SORTERS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 70 LATIN AMERICA: MARKET FOR CELL SORTERS, BY COUNTRY, 2021–2028 (USD MILLION)
7.3.2.1 High-range cell sorters
7.3.2.1.1 High adoption among core laboratories due to procedural benefits to drive market
TABLE 71 MARKET FOR HIGH-RANGE CELL SORTERS, BY REGION, 2021–2028 (USD MILLION)
TABLE 72 NORTH AMERICA: MARKET FOR HIGH-RANGE CELL SORTERS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 73 EUROPE: MARKET FOR HIGH-RANGE CELL SORTERS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 74 ASIA PACIFIC: MARKET FOR HIGH-RANGE CELL SORTERS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 75 LATIN AMERICA: MARKET FOR HIGH-RANGE CELL SORTERS, BY COUNTRY, 2021–2028 (USD MILLION)
7.3.2.2 Mid-range cell sorters
7.3.2.2.1 Cost-efficiency and frequent product launches to drive market
TABLE 76 MARKET FOR MID-RANGE CELL SORTERS, BY REGION, 2021–2028 (USD MILLION)
TABLE 77 NORTH AMERICA: MARKET FOR MID-RANGE CELL SORTERS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 78 EUROPE: MARKET FOR MID-RANGE CELL SORTERS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 79 ASIA PACIFIC: MARKET FOR MID-RANGE CELL SORTERS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 80 LATIN AMERICA: MARKET FOR MID-RANGE CELL SORTERS, BY COUNTRY, 2021–2028 (USD MILLION)
7.3.2.3 Low-range cell sorters
7.3.2.3.1 Increasing use in small labs and research facilities to drive market
TABLE 81 MARKET FOR LOW-RANGE CELL SORTERS, BY REGION, 2021–2028 (USD MILLION)
TABLE 82 NORTH AMERICA: MARKET FOR LOW-RANGE CELL SORTERS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 83 EUROPE: MARKET FOR LOW-RANGE CELL SORTERS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 84 ASIA PACIFIC: MARKET FOR LOW-RANGE CELL SORTERS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 85 LATIN AMERICA: MARKET FOR LOW-RANGE CELL SORTERS, BY COUNTRY, 2021–2028 (USD MILLION)
7.4 SERVICES
7.4.1 ABILITY TO ENSURE WORKFLOW CONTINUITY AND MAXIMIZE PERFORMANCE TO DRIVE MARKET
TABLE 86 MARKET FOR SERVICES, BY REGION, 2021–2028 (USD MILLION)
TABLE 87 NORTH AMERICA: MARKET FOR SERVICES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 88 EUROPE: MARKET FOR SERVICES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 89 ASIA PACIFIC: MARKET FOR SERVICES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 90 LATIN AMERICA: MARKET FOR SERVICES, BY COUNTRY, 2021–2028 (USD MILLION)
7.5 SOFTWARE
7.5.1 GROWING AVAILABILITY OF TECHNOLOGICALLY ADVANCED DATA ANALYSIS SOFTWARE TO DRIVE MARKET
TABLE 91 MARKET FOR SOFTWARE, BY REGION, 2021–2028 (USD MILLION)
7.6 ACCESSORIES
7.6.1 PROCEDURAL BENEFITS OF CUSTOMIZATION AND UPGRADES TO SUPPORT MARKET GROWTH
TABLE 92 MARKET FOR ACCESSORIES, BY REGION, 2021–2028 (USD MILLION)
8 FLOW CYTOMETRY MARKET, BY APPLICATION (Page No. - 151)
8.1 INTRODUCTION
TABLE 93 FLOW CYTOMETRY INDUSTRY, BY APPLICATION, 2021–2028 (USD MILLION)
8.2 RESEARCH APPLICATIONS
TABLE 94 MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 95 MARKET FOR RESEARCH APPLICATIONS, BY REGION, 2021–2028 (USD MILLION)
TABLE 96 NORTH AMERICA: MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 97 EUROPE: MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 98 ASIA PACIFIC: MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 99 LATIN AMERICA: MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
8.2.1 PHARMACEUTICAL & BIOTECHNOLOGY
TABLE 100 MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY, BY TYPE, 2021–2028 (USD MILLION)
TABLE 101 MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY, BY REGION, 2021–2028 (USD MILLION)
TABLE 102 NORTH AMERICA: MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 103 EUROPE: MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 104 ASIA PACIFIC: MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 105 LATIN AMERICA: MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY, BY COUNTRY, 2021–2028 (USD MILLION)
8.2.1.1 Drug discovery
8.2.1.1.1 Growing use of phenotypic cell-based assays in drug discovery to drive market
TABLE 106 MARKET FOR DRUG DISCOVERY, BY REGION, 2021–2028 (USD MILLION)
TABLE 107 NORTH AMERICA: MARKET FOR DRUG DISCOVERY, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 108 EUROPE: MARKET FOR DRUG DISCOVERY, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 109 ASIA PACIFIC: MARKET FOR DRUG DISCOVERY, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 110 LATIN AMERICA: MARKET FOR DRUG DISCOVERY, BY COUNTRY, 2021–2028 (USD MILLION)
8.2.1.2 Stem cell research
8.2.1.2.1 Rising incidence of cancer to propel market
TABLE 111 MARKET FOR STEM CELL RESEARCH, BY REGION, 2021–2028 (USD MILLION)
TABLE 112 NORTH AMERICA: MARKET FOR STEM CELL RESEARCH, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 113 EUROPE: MARKET FOR STEM CELL RESEARCH, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 114 ASIA PACIFIC: MARKET FOR STEM CELL RESEARCH, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 115 LATIN AMERICA: MARKET FOR STEM CELL RESEARCH, BY COUNTRY, 2021–2028 (USD MILLION)
8.2.1.3 In vitro toxicity testing
8.2.1.3.1 Rising need to curtail drug attrition rates to support market growth
TABLE 116 MARKET FOR IN VITRO TOXICITY TESTING, BY REGION, 2021–2028 (USD MILLION)
TABLE 117 NORTH AMERICA: MARKET FOR IN VITRO TOXICITY TESTING, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 118 EUROPE: MARKET FOR IN VITRO TOXICITY TESTING, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 119 ASIA PACIFIC: MARKET FOR IN VITRO TOXICITY TESTING, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 120 LATIN AMERICA: MARKET FOR IN VITRO TOXICITY TESTING, BY COUNTRY, 2021–2028 (USD MILLION)
8.2.2 IMMUNOLOGY
8.2.2.1 Increasing prevalence of infectious & autoimmune diseases to drive market
TABLE 121 MARKET FOR IMMUNOLOGY, BY REGION, 2021–2028 (USD MILLION)
TABLE 122 NORTH AMERICA: MARKET FOR IMMUNOLOGY, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 123 EUROPE: MARKET FOR IMMUNOLOGY, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 124 ASIA PACIFIC: MARKET FOR IMMUNOLOGY, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 125 LATIN AMERICA: MARKET FOR IMMUNOLOGY, BY COUNTRY, 2021–2028 (USD MILLION)
8.2.3 CELL SORTING
8.2.3.1 Development of technologically advanced cell sorters to drive market
TABLE 126 MARKET FOR CELL SORTING, BY REGION, 2021–2028 (USD MILLION)
TABLE 127 NORTH AMERICA: MARKET FOR CELL SORTING, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 128 EUROPE: MARKET FOR CELL SORTING, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 129 ASIA PACIFIC: MARKET FOR CELL SORTING, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 130 LATIN AMERICA: MARKET FOR CELL SORTING, BY COUNTRY, 2021–2028 (USD MILLION)
8.2.4 APOPTOSIS
8.2.4.1 Wide availability of apoptosis assays to support market growth
TABLE 131 MARKET FOR APOPTOSIS, BY REGION, 2021–2028 (USD MILLION)
TABLE 132 NORTH AMERICA: MARKET FOR APOPTOSIS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 133 EUROPE: MARKET FOR APOPTOSIS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 134 ASIA PACIFIC: MARKET FOR APOPTOSIS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 135 LATIN AMERICA: MARKET FOR APOPTOSIS, BY COUNTRY, 2021–2028 (USD MILLION)
8.2.5 CELL CYCLE ANALYSIS
8.2.5.1 Ability to detect chromosomal abnormalities to propel market
TABLE 136 MARKET FOR CELL CYCLE ANALYSIS, BY REGION, 2021–2028 (USD MILLION)
TABLE 137 NORTH AMERICA: MARKET FOR CELL CYCLE ANALYSIS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 138 EUROPE: MARKET FOR CELL CYCLE ANALYSIS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 139 ASIA PACIFIC: MARKET FOR CELL CYCLE ANALYSIS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 140 LATIN AMERICA: MARKET FOR CELL CYCLE ANALYSIS, BY COUNTRY, 2021–2028 (USD MILLION)
8.2.6 CELL VIABILITY
8.2.6.1 Assessing physiological characteristics of specific target cells to support market growth
TABLE 141 MARKET FOR CELL VIABILITY, BY REGION, 2021–2028 (USD MILLION)
TABLE 142 NORTH AMERICA: MARKET FOR CELL VIABILITY, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 143 EUROPE: MARKET FOR CELL VIABILITY, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 144 ASIA PACIFIC: MARKET FOR CELL VIABILITY, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 145 LATIN AMERICA: MARKET FOR CELL VIABILITY, BY COUNTRY, 2021–2028 (USD MILLION)
8.2.7 CELL COUNTING
8.2.7.1 Ability to simultaneously analyze additional parameters with high accuracy to drive market
TABLE 146 MARKET FOR CELL COUNTING, BY REGION, 2021–2028 (USD MILLION)
TABLE 147 NORTH AMERICA: MARKET FOR CELL COUNTING, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 148 EUROPE: MARKET FOR CELL COUNTING, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 149 ASIA PACIFIC: MARKET FOR CELL COUNTING, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 150 LATIN AMERICA: MARKET FOR CELL COUNTING, BY COUNTRY, 2021–2028 (USD MILLION)
8.2.8 OTHER RESEARCH APPLICATIONS
TABLE 151 MARKET FOR OTHER RESEARCH APPLICATIONS, BY REGION, 2021–2028 (USD MILLION)
TABLE 152 NORTH AMERICA: MARKET FOR OTHER RESEARCH APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 153 EUROPE: MARKET FOR OTHER RESEARCH APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 154 ASIA PACIFIC: MARKET FOR OTHER RESEARCH APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 155 LATIN AMERICA: MARKET FOR OTHER RESEARCH APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
8.3 CLINICAL APPLICATIONS
TABLE 156 MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 157 MARKET FOR CLINICAL APPLICATIONS, BY REGION, 2021–2028 (USD MILLION)
TABLE 158 NORTH AMERICA: MARKET FOR CLINICAL APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 159 EUROPE: MARKET FOR CLINICAL APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 160 ASIA PACIFIC: MARKET FOR CLINICAL APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 161 LATIN AMERICA: MARKET FOR CLINICAL APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
8.3.1 CANCER
8.3.1.1 Rising use in prediction of cancer recurrence to drive market
TABLE 162 ESTIMATED NUMBER OF NEW CANCER CASES (2020 -2040)
TABLE 163 MARKET FOR CANCER, BY REGION, 2021–2028 (USD MILLION)
TABLE 164 NORTH AMERICA: MARKET FOR CANCER, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 165 EUROPE: MARKET FOR CANCER, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 166 ASIA PACIFIC: MARKET FOR CANCER, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 167 LATIN AMERICA: MARKET FOR CANCER, BY COUNTRY, 2021–2028 (USD MILLION)
8.3.2 HEMATOLOGY
8.3.2.1 Assessment in hematopoiesis and bone marrow function to drive market
TABLE 168 MARKET FOR HEMATOLOGY, BY REGION, 2021–2028 (USD MILLION)
TABLE 169 NORTH AMERICA: MARKET FOR HEMATOLOGY, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 170 EUROPE: MARKET FOR HEMATOLOGY, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 171 ASIA PACIFIC: MARKET FOR HEMATOLOGY, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 172 LATIN AMERICA: MARKET FOR HEMATOLOGY, BY COUNTRY, 2021–2028 (USD MILLION)
8.3.3 IMMUNODEFICIENCY DISEASES
8.3.3.1 Detection of HIV infection and analysis of antigen-specific T-cells to propel market
TABLE 173 APPLICATION OF FLOW CYTOMETRY IN DIAGNOSIS OF PRIMARY IMMUNODEFICIENCY DISEASES
TABLE 174 MARKET FOR IMMUNODEFICIENCY DISEASES, BY REGION, 2021–2028 (USD MILLION)
TABLE 175 NORTH AMERICA: MARKET FOR IMMUNODEFICIENCY DISEASES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 176 EUROPE: MARKET FOR IMMUNODEFICIENCY DISEASES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 177 ASIA PACIFIC: MARKET FOR IMMUNODEFICIENCY DISEASES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 178 LATIN AMERICA: MARKET FOR IMMUNODEFICIENCY DISEASES, BY COUNTRY, 2021–2028 (USD MILLION)
8.3.4 ORGAN & TISSUE TRANSPLANTATION
8.3.4.1 Detection of specific antibodies for donor selection to drive market
TABLE 179 MARKET FOR ORGAN & TISSUE TRANSPLANTATION, BY REGION, 2021–2028 (USD MILLION)
TABLE 180 NORTH AMERICA: MARKET FOR ORGAN & TISSUE TRANSPLANTATION, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 181 EUROPE: MARKET FOR ORGAN & TISSUE TRANSPLANTATION, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 182 ASIA PACIFIC: MARKET FOR ORGAN & TISSUE TRANSPLANTATION, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 183 LATIN AMERICA: MARKET FOR ORGAN & TISSUE TRANSPLANTATION, BY COUNTRY, 2021–2028 (USD MILLION)
8.3.5 OTHER CLINICAL APPLICATIONS
TABLE 184 MARKET FOR OTHER CLINICAL APPLICATIONS, BY REGION, 2021–2028 (USD MILLION)
TABLE 185 NORTH AMERICA: MARKET FOR OTHER CLINICAL APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 186 EUROPE: MARKET FOR OTHER CLINICAL APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 187 ASIA PACIFIC: MARKET FOR OTHER CLINICAL APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 188 LATIN AMERICA: MARKET FOR OTHER CLINICAL APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
8.4 INDUSTRIAL APPLICATIONS
8.4.1 RISING USE IN ENERGY AND FOOD & DAIRY SECTORS TO SUPPORT MARKET GROWTH
TABLE 189 MARKET FOR INDUSTRIAL APPLICATIONS, BY REGION, 2021–2028 (USD MILLION)
TABLE 190 NORTH AMERICA: MARKET FOR INDUSTRIAL APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 191 EUROPE: MARKET FOR INDUSTRIAL APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 192 ASIA PACIFIC: MARKET FOR INDUSTRIAL APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 193 LATIN AMERICA: MARKET FOR INDUSTRIAL APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
9 FLOW CYTOMETRY MARKET, BY END USER (Page No. - 205)
9.1 INTRODUCTION
TABLE 194 FLOW CYTOMETRY INDUSTRY, BY END USER, 2021–2028 (USD MILLION)
9.2 ACADEMIC AND RESEARCH INSTITUTES
9.2.1 GROWING USE OF FLOW CYTOMETRY IN CANCER & STEM CELL RESEARCH TO DRIVE MARKET
TABLE 195 MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY REGION, 2021–2028 (USD MILLION)
TABLE 196 NORTH AMERICA: MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 197 EUROPE: MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 198 ASIA PACIFIC: MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 199 LATIN AMERICA: MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION)
9.3 HOSPITALS AND CLINICAL TESTING LABORATORIES
9.3.1 RISING USE IN CLINICAL APPLICATIONS FOR INFECTIOUS DISEASE DIAGNOSTICS TO PROPEL MARKET
TABLE 200 MARKET FOR HOSPITALS AND CLINICAL TESTING LABORATORIES, BY REGION, 2021–2028 (USD MILLION)
TABLE 201 NORTH AMERICA: MARKET FOR HOSPITALS AND CLINICAL TESTING LABORATORIES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 202 EUROPE: MARKET FOR HOSPITALS AND CLINICAL TESTING LABORATORIES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 203 ASIA PACIFIC: MARKET FOR HOSPITALS AND CLINICAL TESTING LABORATORIES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 204 LATIN AMERICA: MARKET FOR HOSPITALS AND CLINICAL TESTING LABORATORIES, BY COUNTRY, 2021–2028 (USD MILLION)
9.4 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES
9.4.1 INCREASING NUMBER OF CLINICAL TRIALS TO SUPPORT MARKET GROWTH
TABLE 205 MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2021–2028 (USD MILLION)
TABLE 206 NORTH AMERICA: MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 207 EUROPE: MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 208 ASIA PACIFIC: MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 209 LATIN AMERICA: MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION)
10 FLOW CYTOMETRY MARKET, BY REGION (Page No. - 216)
10.1 INTRODUCTION
TABLE 210 FLOW CYTOMETRY INDUSTRY, BY REGION, 2021–2028 (USD MILLION)
10.2 NORTH AMERICA
FIGURE 29 NORTH AMERICA: FLOW CYTOMETRY MARKET SNAPSHOT
TABLE 211 NORTH AMERICA: MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 212 NORTH AMERICA: MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 213 NORTH AMERICA: MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 214 NORTH AMERICA: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 215 NORTH AMERICA: FLOW CYTOMETRY CELL ANALYZERS MARKET, BY PRICE RANGE, 2021–2028 (USD MILLION)
TABLE 216 NORTH AMERICA: FLOW CYTOMETRY CELL SORTERS MARKET, BY PRICE RANGE, 2021–2028 (USD MILLION)
TABLE 217 NORTH AMERICA: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 218 NORTH AMERICA: MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 219 NORTH AMERICA: MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY, BY TYPE, 2021–2028 (USD MILLION)
TABLE 220 NORTH AMERICA: MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 221 NORTH AMERICA: MARKET, BY END USER, 2021–2028 (USD MILLION)
10.2.1 US
10.2.1.1 High incidence of cancer and HIV/AIDS to drive market
TABLE 222 US: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 223 US: MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 224 US: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 225 US: FLOW CYTOMETRY CELL ANALYZERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 226 US: FLOW CYTOMETRY CELL SORTERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 227 US: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 228 US: MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 229 US: MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY, BY TYPE, 2021–2028 (USD MILLION)
TABLE 230 US: MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 231 US: MARKET, BY END USER, 2021–2028 (USD MILLION)
10.2.2 CANADA
10.2.2.1 Ongoing government initiatives for life sciences research to propel market
TABLE 232 CANADA: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 233 CANADA: MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 234 CANADA: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 235 CANADA: FLOW CYTOMETRY CELL ANALYZERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 236 CANADA: FLOW CYTOMETRY CELL SORTERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 237 CANADA: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 238 CANADA: MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 239 CANADA: MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY, BY TYPE, 2021–2028 (USD MILLION)
TABLE 240 CANADA: MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 241 CANADA: FLOW CYTOMETRY INDUSTRY, BY END USER, 2021–2028 (USD MILLION)
10.2.3 NORTH AMERICA: RECESSION IMPACT
10.3 EUROPE
TABLE 242 EUROPE: FLOW CYTOMETRY MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 243 EUROPE: MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 244 EUROPE: MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 245 EUROPE: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 246 EUROPE: FLOW CYTOMETRY CELL ANALYZERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 247 EUROPE: FLOW CYTOMETRY CELL SORTERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 248 EUROPE: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 249 EUROPE: MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 250 EUROPE: MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY, BY TYPE, 2021–2028 (USD MILLION)
TABLE 251 EUROPE: MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 252 EUROPE: MARKET, BY END USER, 2021–2028 (USD MILLION)
10.3.1 GERMANY
10.3.1.1 Strong base for R&D and growing awareness initiatives on flow cytometry to drive market
TABLE 253 GERMANY: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 254 GERMANY: MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 255 GERMANY: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 256 GERMANY: FLOW CYTOMETRY CELL ANALYZERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 257 GERMANY: FLOW CYTOMETRY CELL SORTERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 258 GERMANY: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 259 GERMANY: MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 260 GERMANY: MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY, BY TYPE, 2021–2028 (USD MILLION)
TABLE 261 GERMANY: MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 262 GERMANY: MARKET, BY END USER, 2021–2028 (USD MILLION)
10.3.2 UK
10.3.2.1 Increasing academic initiatives for cancer research to propel market
TABLE 263 UK: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 264 UK: MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 265 UK: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 266 UK: FLOW CYTOMETRY CELL ANALYZERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 267 UK: FLOW CYTOMETRY CELL SORTERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 268 UK: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 269 UK: MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 270 UK: MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY, BY TYPE, 2021–2028 (USD MILLION)
TABLE 271 UK: MARKET FOR BY CLINICAL APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 272 UK: FLOW CYTOMETRY INDUSTRY, BY END USER, 2021–2028 (USD MILLION)
10.3.3 FRANCE
10.3.3.1 Rising government funding for proteomics & genomics research to drive market
TABLE 273 FRANCE: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 274 FRANCE: MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 275 FRANCE: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 276 FRANCE: FLOW CYTOMETRY CELL ANALYZERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 277 FRANCE: FLOW CYTOMETRY CELL SORTERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 278 FRANCE: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 279 FRANCE: MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 280 FRANCE: MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY, BY TYPE, 2021–2028 (USD MILLION)
TABLE 281 FRANCE: MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 282 FRANCE: MARKET, BY END USER, 2021–2028 (USD MILLION)
10.3.4 ITALY
10.3.4.1 Increasing investments in life science research to drive market
TABLE 283 ITALY: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 284 ITALY: MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 285 ITALY: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 286 ITALY: FLOW CYTOMETRY CELL ANALYZERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 287 ITALY: FLOW CYTOMETRY CELL SORTERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 288 ITALY: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 289 ITALY: MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 290 ITALY: MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY, BY TYPE, 2021–2028 (USD MILLION)
TABLE 291 ITALY: MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 292 ITALY: MARKET, BY END USER, 2021–2028 (USD MILLION)
10.3.5 SPAIN
10.3.5.1 Rising focus on cancer biomarkers to fuel market
TABLE 293 SPAIN: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 294 SPAIN: MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 295 SPAIN: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 296 SPAIN: FLOW CYTOMETRY CELL ANALYZERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 297 SPAIN: FLOW CYTOMETRY CELL SORTERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 298 SPAIN: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 299 SPAIN: MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 300 SPAIN: MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY, BY TYPE, 2021–2028 (USD MILLION)
TABLE 301 SPAIN: MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 302 SPAIN: FLOW CYTOMETRY INDUSTRY, BY END USER, 2021–2028 (USD MILLION)
10.3.6 REST OF EUROPE
TABLE 303 REST OF EUROPE: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 304 REST OF EUROPE: MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 305 REST OF EUROPE: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 306 REST OF EUROPE: FLOW CYTOMETRY CELL ANALYZERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 307 REST OF EUROPE: FLOW CYTOMETRY CELL SORTERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 308 REST OF EUROPE: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 309 REST OF EUROPE: MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 310 REST OF EUROPE: MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY, BY TYPE, 2021–2028 (USD MILLION)
TABLE 311 REST OF EUROPE: MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 312 REST OF EUROPE: MARKET, BY END USER, 2021–2028 (USD MILLION)
10.3.7 EUROPE: RECESSION IMPACT
10.4 ASIA PACIFIC
FIGURE 30 ASIA PACIFIC: FLOW CYTOMETRY MARKET SNAPSHOT
TABLE 313 ASIA PACIFIC: MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 314 ASIA PACIFIC: MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 315 ASIA PACIFIC: MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 316 ASIA PACIFIC: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 317 ASIA PACIFIC: FLOW CYTOMETRY CELL ANALYZERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 318 ASIA PACIFIC: FLOW CYTOMETRY CELL SORTERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 319 ASIA PACIFIC: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 320 ASIA PACIFIC: MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 321 ASIA PACIFIC: MARKET, BY PHARMACEUTICAL & BIOTECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 322 ASIA PACIFIC: MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 323 ASIA PACIFIC: MARKET, BY END USER, 2021–2028 (USD MILLION)
10.4.1 JAPAN
10.4.1.1 Growing focus on development of advanced single-cell therapies to drive market
TABLE 324 JAPAN: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 325 JAPAN: MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 326 JAPAN: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 327 JAPAN: FLOW CYTOMETRY CELL ANALYZERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 328 JAPAN: FLOW CYTOMETRY CELL SORTERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 329 JAPAN: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 330 JAPAN: MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 331 JAPAN: MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY, BY TYPE, 2021–2028 (USD MILLION)
TABLE 332 JAPAN: MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 333 JAPAN: MARKET, BY END USER, 2021–2028 (USD MILLION)
10.4.2 CHINA
10.4.2.1 High Incidence of target diseases and increasing focus on personalized medicine to drive market
TABLE 334 CHINA: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 335 CHINA: MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 336 CHINA: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 337 CHINA: FLOW CYTOMETRY CELL ANALYZERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 338 CHINA: FLOW CYTOMETRY CELL SORTERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 339 CHINA: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 340 CHINA: MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 341 CHINA: MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY, BY TYPE, 2021–2028 (USD MILLION)
TABLE 342 CHINA: MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 343 CHINA: MARKET, BY END USER, 2021–2028 (USD MILLION)
10.4.3 INDIA
10.4.3.1 Rising government funding for research in proteomics technologies to drive market
TABLE 344 INDIA: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 345 INDIA: MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 346 INDIA: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 347 INDIA: FLOW CYTOMETRY CELL ANALYZERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 348 INDIA: FLOW CYTOMETRY CELL SORTERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 349 INDIA: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 350 INDIA: MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 351 INDIA: MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY, BY TYPE, 2021–2028 (USD MILLION)
TABLE 352 INDIA: MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 353 INDIA: FLOW CYTOMETRY INDUSTRY, BY END USER, 2021–2028 (USD MILLION)
10.4.4 AUSTRALIA
10.4.4.1 Increasing investments in life sciences research to support market growth
TABLE 354 AUSTRALIA: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 355 AUSTRALIA: MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 356 AUSTRALIA: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 357 AUSTRALIA: FLOW CYTOMETRY CELL ANALYZERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 358 AUSTRALIA: FLOW CYTOMETRY CELL SORTERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 359 AUSTRALIA: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 360 AUSTRALIA: MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 361 AUSTRALIA: MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY, BY TYPE, 2021–2028 (USD MILLION)
TABLE 362 AUSTRALIA: MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 363 AUSTRALIA: MARKET, BY END USER, 2021–2028 (USD MILLION)
10.4.5 SOUTH KOREA
10.4.5.1 Rising growth in biotech industry to propel market
TABLE 364 SOUTH KOREA: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 365 SOUTH KOREA: MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 366 SOUTH KOREA: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 367 SOUTH KOREA: FLOW CYTOMETRY CELL ANALYZERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 368 SOUTH KOREA: FLOW CYTOMETRY CELL SORTERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 369 SOUTH KOREA: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 370 SOUTH KOREA: MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 371 SOUTH KOREA: MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY, BY TYPE, 2021–2028 (USD MILLION)
TABLE 372 SOUTH KOREA: MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 373 SOUTH KOREA: MARKET, BY END USER, 2021–2028 (USD MILLION)
10.4.6 SINGAPORE
10.4.6.1 Launch of novel technologies for flow cytometry research to support market growth
TABLE 374 SINGAPORE: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 375 SINGAPORE: MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 376 SINGAPORE: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 377 SINGAPORE: FLOW CYTOMETRY CELL ANALYZERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 378 SINGAPORE: FLOW CYTOMETRY CELL SORTERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 379 SINGAPORE: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 380 SINGAPORE: MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 381 SINGAPORE: MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY, BY TYPE, 2021–2028 (USD MILLION)
TABLE 382 SINGAPORE: MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 383 SINGAPORE: MARKET, BY END USER, 2021–2028 (USD MILLION)
10.4.7 INDONESIA
10.4.7.1 Increasing collaborations between academic institutes for stem cell research to drive market
TABLE 384 INDONESIA: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 385 INDONESIA: MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 386 INDONESIA: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 387 INDONESIA: FLOW CYTOMETRY CELL ANALYZERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 388 INDONESIA: FLOW CYTOMETRY CELL SORTERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 389 INDONESIA: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 390 INDONESIA: MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 391 INDONESIA: MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY, BY TYPE, 2021–2028 (USD MILLION)
TABLE 392 INDONESIA: MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 393 INDONESIA: FLOW CYTOMETRY INDUSTRY, BY END USER, 2021–2028 (USD MILLION)
10.4.8 REST OF ASIA PACIFIC
TABLE 394 REST OF ASIA PACIFIC: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 395 REST OF ASIA PACIFIC: MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 396 REST OF ASIA PACIFIC: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 397 REST OF ASIA PACIFIC: FLOW CYTOMETRY CELL ANALYZERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 398 REST OF ASIA PACIFIC: FLOW CYTOMETRY CELL SORTERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 399 REST OF ASIA PACIFIC: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 400 REST OF ASIA PACIFIC: MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 401 REST OF ASIA PACIFIC: MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 402 REST OF ASIA PACIFIC: MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 403 REST OF ASIA PACIFIC: MARKET, BY END USER, 2021–2028 (USD MILLION)
10.4.9 ASIA PACIFIC: RECESSION IMPACT
10.5 LATIN AMERICA
TABLE 404 LATIN AMERICA: FLOW CYTOMETRY MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 405 LATIN AMERICA: MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 406 LATIN AMERICA: MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 407 LATIN AMERICA: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 408 LATIN AMERICA: FLOW CYTOMETRY CELL ANALYZERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 409 LATIN AMERICA: FLOW CYTOMETRY CELL SORTERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 410 LATIN AMERICA: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 411 LATIN AMERICA: MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 412 LATIN AMERICA: MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY, BY TYPE, 2021–2028 (USD MILLION)
TABLE 413 LATIN AMERICA: MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 414 LATIN AMERICA: MARKET, BY END USER, 2021–2028 (USD MILLION)
10.5.1 BRAZIL
10.5.1.1 Government initiatives for advancements in scientific research to support market growth
TABLE 415 BRAZIL: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 416 BRAZIL: MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 417 BRAZIL: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 418 BRAZIL: FLOW CYTOMETRY CELL ANALYZERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 419 BRAZIL: FLOW CYTOMETRY CELL SORTERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 420 BRAZIL: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 421 BRAZIL: MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 422 BRAZIL: MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY, BY TYPE, 2021–2028 (USD MILLION)
TABLE 423 BRAZIL: MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 424 BRAZIL: MARKET, BY END USER, 2021–2028 (USD MILLION)
10.5.2 MEXICO
10.5.2.1 Favorable trade agreements for flow cytometry instruments to propel market
TABLE 425 MEXICO: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 426 MEXICO: MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 427 MEXICO: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 428 MEXICO: FLOW CYTOMETRY CELL ANALYZERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 429 MEXICO: FLOW CYTOMETRY CELL SORTERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 430 MEXICO: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 431 MEXICO: MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 432 MEXICO: MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY, BY TYPE, 2021–2028 (USD MILLION)
TABLE 433 MEXICO: MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 434 MEXICO: MARKET, BY END USER, 2021–2028 (USD MILLION)
10.5.3 REST OF LATIN AMERICA
TABLE 435 REST OF LATIN AMERICA: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 436 REST OF LATIN AMERICA: MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 437 REST OF LATIN AMERICA: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 438 REST OF LATIN AMERICA: FLOW CYTOMETRY CELL ANALYZERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 439 REST OF LATIN AMERICA: FLOW CYTOMETRY CELL SORTERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 440 REST OF LATIN AMERICA: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 441 REST OF LATIN AMERICA: MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 442 REST OF LATIN AMERICA: MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY, BY TYPE, 2021–2028 (USD MILLION)
TABLE 443 REST OF LATIN AMERICA: MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 444 REST OF LATIN AMERICA: MARKET, BY END USER, 2021–2028 (USD MILLION)
10.5.4 LATIN AMERICA: RECESSION IMPACT
10.6 MIDDLE EAST & AFRICA
10.6.1 IMPROVEMENTS IN HEALTHCARE INFRASTRUCTURE TO SUPPORT MARKET GROWTH
TABLE 445 MIDDLE EAST & AFRICA: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 446 MIDDLE EAST & AFRICA: MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 447 MIDDLE EAST & AFRICA: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 448 MIDDLE EAST & AFRICA: FLOW CYTOMETRY CELL ANALYZERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 449 MIDDLE EAST & AFRICA: FLOW CYTOMETRY CELL SORTERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 450 MIDDLE EAST & AFRICA: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 451 MIDDLE EAST & AFRICA: MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 452 MIDDLE EAST & AFRICA: MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY, BY TYPE, 2021–2028 (USD MILLION)
TABLE 453 MIDDLE EAST & AFRICA: MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 454 MIDDLE EAST & AFRICA: FLOW CYTOMETRY INDUSTRY, BY END USER, 2021–2028 (USD MILLION)
10.6.2 MIDDLE EAST & AFRICA: RECESSION IMPACT
11 COMPETITIVE LANDSCAPE (Page No. - 336)
11.1 INTRODUCTION
FIGURE 31 FLOW CYTOMETRY MARKET: STRATEGIES ADOPTED BY KEY PLAYERS
11.2 REVENUE SHARE ANALYSIS
FIGURE 32 FLOW CYTOMETRY INDUSTRY: REVENUE SHARE ANALYSIS OF KEY PLAYERS (2022)
11.3 MARKET SHARE ANALYSIS
FIGURE 33 MARKET: MARKET SHARE ANALYSIS OF KEY PLAYERS (2022)
TABLE 455 MARKET: INTENSITY OF COMPETITIVE RIVALRY
11.4 COMPANY EVALUATION MATRIX
11.4.1 STARS
11.4.2 EMERGING LEADERS
11.4.3 PERVASIVE PLAYERS
11.4.4 PARTICIPANTS
FIGURE 34 MARKET: COMPANY EVALUATION MATRIX FOR KEY PLAYERS (2022)
11.5 COMPETITIVE BENCHMARKING OF LEADING PLAYERS
11.5.1 COMPANY PRODUCT FOOTPRINT
TABLE 456 MARKET: PRODUCT FOOTPRINT ANALYSIS
11.5.2 COMPANY REGIONAL FOOTPRINT
TABLE 457 MARKET: REGIONAL FOOTPRINT ANALYSIS
11.6 COMPANY EVALUATION MATRIX FOR STARTUPS/SMES
11.6.1 PROGRESSIVE COMPANIES
11.6.2 STARTING BLOCKS
11.6.3 RESPONSIVE COMPANIES
11.6.4 DYNAMIC COMPANIES
FIGURE 35 MARKET: COMPANY EVALUATION MATRIX FOR STARTUPS/SMES (2022)
11.7 COMPETITIVE BENCHMARKING OF STARTUPS/SMES
TABLE 458 MARKET: DETAILED LIST OF KEY STARTUPS/SMES (2022)
TABLE 459 MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SMES (2022)
11.8 COMPETITIVE SCENARIO AND TRENDS
11.8.1 PRODUCT LAUNCHES
TABLE 460 MARKET: PRODUCT LAUNCHES (JANUARY 2020−JULY 2023)
11.8.2 DEALS
TABLE 461 MARKET: DEALS (JANUARY 2020−JUNE 2023)
11.8.3 OTHER DEVELOPMENTS
TABLE 462 FLOW CYTOMETRY MARKET: OTHER DEVELOPMENTS (JANUARY 2020–APRIL 2023)
12 COMPANY PROFILES (Page No. - 349)
12.1 KEY PLAYERS
(Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments)*
12.1.1 BD
TABLE 463 BD: BUSINESS OVERVIEW
FIGURE 36 BD: COMPANY SNAPSHOT (2022)
12.1.2 DANAHER CORPORATION
TABLE 464 DANAHER CORPORATION: BUSINESS OVERVIEW
FIGURE 37 DANAHER CORPORATION: COMPANY SNAPSHOT (2022)
12.1.3 THERMO FISHER SCIENTIFIC, INC.
TABLE 465 THERMO FISHER SCIENTIFIC, INC.: BUSINESS OVERVIEW
FIGURE 38 THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT (2022)
12.1.4 AGILENT TECHNOLOGIES, INC.
TABLE 466 AGILENT TECHNOLOGIES, INC.: BUSINESS OVERVIEW
FIGURE 39 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2022)
12.1.5 SONY BIOTECHNOLOGY INC. (SUBSIDIARY OF SONY CORPORATION)
TABLE 467 SONY CORPORATION: BUSINESS OVERVIEW
FIGURE 40 SONY CORPORATION: COMPANY SNAPSHOT (2022)
12.1.6 BIO-RAD LABORATORIES, INC.
TABLE 468 BIO-RAD LABORATORIES, INC.: BUSINESS OVERVIEW
FIGURE 41 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2022)
12.1.7 MILTENYI BIOTEC
TABLE 469 MILTENYI BIOTEC: BUSINESS OVERVIEW
12.1.8 ENZO BIOCHEM, INC.
TABLE 470 ENZO BIOCHEM, INC.: BUSINESS OVERVIEW
FIGURE 42 ENZO BIOCHEM, INC.: COMPANY SNAPSHOT (2022)
12.1.9 SYSMEX CORPORATION
TABLE 471 SYSMEX CORPORATION: BUSINESS OVERVIEW
FIGURE 43 SYSMEX CORPORATION: COMPANY SNAPSHOT (2022)
12.1.10 BIOMÉRIEUX
TABLE 472 BIOMÉRIEUX: BUSINESS OVERVIEW
FIGURE 44 BIOMÉRIEUX: COMPANY SNAPSHOT (2022)
12.1.11 CYTONOME/ST, LLC.
TABLE 473 CYTONOME/ST, LLC.: BUSINESS OVERVIEW
12.1.12 SARTORIUS AG
TABLE 474 SARTORIUS AG: BUSINESS OVERVIEW
FIGURE 45 SARTORIUS AG: COMPANY SNAPSHOT (2022)
12.1.13 CYTEK BIOSCIENCES
TABLE 475 CYTEK BIOSCIENCES: BUSINESS OVERVIEW
FIGURE 46 CYTEK BIOSCIENCES: COMPANY SNAPSHOT (2022)
12.1.14 UNION BIOMETRICA, INC.
TABLE 476 UNION BIOMETRICA, INC.: BUSINESS OVERVIEW
12.1.15 LUMINEX CORPORATION (A DIASORIN COMPANY)
TABLE 477 DIASORIN S.P.A.: BUSINESS OVERVIEW
FIGURE 47 DIASORIN S.P.A.: COMPANY SNAPSHOT (2022)
*Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments might not be captured in case of unlisted companies.
12.2 OTHER PLAYERS
12.2.1 APOGEE FLOW SYSTEMS LTD.
12.2.2 STRATEDIGM, INC.
12.2.3 NANOCELLECT BIOMEDICAL, INC.
12.2.4 ON-CHIP BIOTECHNOLOGIES CO., LTD.
12.2.5 NEXCELOM BIOSCIENCE LLC.
12.2.6 BENNUBIO, INC.
12.2.7 ORFLO TECHNOLOGIES
12.2.8 BAY BIOSCIENCES LLC.
12.2.9 CYTOBUOY B.V.
12.2.10 BIOLEGEND, INC.
13 APPENDIX (Page No. - 408)
13.1 DISCUSSION GUIDE
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
13.3 CUSTOMIZATION OPTIONS
13.4 RELATED REPORTS
13.5 AUTHOR DETAILS
This research study involved the extensive use of secondary sources, directories, and databases to identify and collect valuable information for the analysis of the global flow cytometry market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative and quantitative information and assess the growth prospects of the market. The global market size estimated through secondary research was then triangulated with inputs from primary research to arrive at the final market size.
Secondary Research
Secondary research was used mainly to identify and collect information for the extensive, technical, market-oriented, and commercial study of the flow cytometry market. The secondary sources used for this study include the World Health Organization (WHO), the Organization for Economic Co-operation and Development (OECD), the Global Cancer Observatory (GLOBOCAN), the World Bank, Eurostat, the Joint United Nations Programme on HIV/AIDS (UNAIDS), the National Institutes of Health (NIH), Institute for Health Metrics and Evaluation (US), International Society for Advancement of Cytometry (US), US FDA, Health Canada, EuroStemCell, German Cancer Research Center, NHS (UK), Cancer Research UK (UK), Stem Cell Foundation, French National Research Agency (France), Italian National Institute of Health, National Cancer Center Japan, Ministry of Science & Technology (India), Australasian Cytometry Society (Australia), the Cytometry Society (India), International Clinical Cytometry Society (US), and African Cancer Registry Network; Lens. Org. National Center for Biotechnology Information (NCBI), corporate filings such as annual reports, SEC filings, investor presentations, and financial statements; research journals; press releases; and trade, business, professional associations, and among others. These sources were also used to obtain key information about major players, market classification, and segmentation according to industry trends, regional/country-level markets, market developments, and technology perspectives.
Primary Research
Extensive primary research was conducted after acquiring basic knowledge about the global flow cytometry market scenario through secondary research. Several primary interviews were conducted with market experts from the demand side, such as personnel from pharmaceutical and biopharmaceutical industries, CMOs and CROs, academic & research institutes, and experts from the supply side, such as C-level and D-level executives, product managers, marketing & sales managers of key manufacturers, distributors, and channel partners. These interviews were conducted across four major regions, including the Asia Pacific, North America, Europe, Latin America, and the Middle East & Africa. Approximately 70% and 30% of the primary interviews were conducted with supply-side and demand-side participants, respectively. This primary data was collected through questionnaires, e-mails, online surveys, personal interviews, and telephonic interviews.
The following is a breakdown of the primary respondents:
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
The global size of the market was estimated through multiple approaches. A detailed market estimation approach was followed to estimate and validate the value of the flow cytometry market and other dependent submarkets. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:
- The key players in the industry and market have been identified through extensive primary and secondary research.
- The revenues generated from the flow cytometry business of leading players have been determined through primary and secondary research.
- All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.
Global Flow Cytometry Market: Bottom-Up Approach
To know about the assumptions considered for the study, Request for Free Sample Report
Global Flow Cytometry Market: Top-Down Approach
Data Triangulation
After arriving at the market size from the market size estimation process explained above, the total market was divided into several segments and subsegments. Data triangulation and market breakdown procedures were employed, wherever applicable, to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.
Market Definition
Flow cytometry is a laser-based technology used to measure & analyze multiple physical characteristics of microscopic particles, including cells (mammalian, plant, algae, yeast, and bacteria); cellular matter (enzymes, proteins, nuclei, RNA, and DNA); and latex beads. Several properties related to cellular structure and functions, such as cell size, cell cycle, cell viability, enzymatic activities, membrane potentials, cellular antigens, DNA/RNA, protein synthesis, and surface receptors, can be analyzed with the help of flow cytometry. Flow cytometry has several applications in scientific research and clinical diagnosis.
Key Stakeholders
- Flow cytometry equipment manufacturers, vendors, and distributors
- Flow cytometry service providers
- R&D companies
- Academia, research institutes, and government organizations
- Venture capitalists and other public-private funding agencies
- Pharmaceutical, cosmeceutical, and biotechnology companies
- Healthcare service providers (including hospitals and diagnostic centers)
- Clinical research organizations (CROs)
- Clinical testing laboratories and service providers
- Market research and consulting firms
- Government and independent regulatory authorities
Report Objectives
- To define, describe, and forecast the global flow cytometry market based on the technology, product & service, application, end-user, and region
- To provide detailed information regarding the major factors influencing the growth of the market (such as drivers, restraints, and opportunities)
- To strategically analyze micro markets with respect to individual growth trends, future prospects, and contributions to the overall cell analysis market
- To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
- To forecast the size of the market segments with respect to five main regions, namely, North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa
- To strategically profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies.
- To track and analyze competitive developments such as acquisitions, product launches, expansions, agreements, partnerships, and R&D activities in the flow cytometry market.
Available Customizations
With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for this report:
Geographical Analysis
- Further breakdown of the Rest of Europe's flow cytometry market, by country
- Further breakdown of the Rest of the Asia Pacific flow cytometry market, by country
- Further breakdown of the Latin America and Middle East & Africa flow cytometry market, by country.
Company Information
- Detailed analysis and profiling of additional market players (up to five)
Segment Analysis
- Further breakdown of the application area segment as per the service portfolio of prominent players operating in the market.
Generating Response ...
Growth opportunities and latent adjacency in Flow Cytometry Market
What are the growth opportunities in the North American region for the global flow cytometry market?
Hi Ash,
Here are some of the leading companies in the flow cytometry market:
1. Becton, Dickinson and Company (BD)
2. Danaher Corporation
3. Thermo Fisher Scientific, Inc.
4. Agilent Technologies, Inc.
5. Bio-Rad Laboratories, Inc.
6. Miltenyi Biotec
7. Sysmex Corporation
8. Stratedigm, Inc.
9. Apogee Flow Systems Ltd.
10. Sony Biotechnology, Inc.
These companies offer a wide range of flow cytometry products and services, including instruments, reagents, software, and consulting. They also play a leading role in the development of new flow cytometry technologies.
The flow cytometry market is expected to grow significantly in the next few years, due to a number of factors, including:
1. The increasing demand for personalized medicine
2. The rising incidence of chronic diseases
3. The development of new flow cytometry technologies
The companies listed above are well-positioned to benefit from the growth of the flow cytometry market. They have the resources, expertise, and track record to continue to innovate and lead the market in the years to come.
Here are some of the factors that are driving the growth of the flow cytometry market:
Increasing demand for personalized medicine: Flow cytometry is a powerful tool that can be used to study the behavior of individual cells. This information can be used to personalize treatments for diseases such as cancer.
Rising incidence of chronic diseases: The incidence of chronic diseases such as cancer, HIV, and autoimmune diseases is on the rise. Flow cytometry is a valuable tool for diagnosing and monitoring these diseases.
Development of new flow cytometry technologies: New flow cytometry technologies are being developed that offer increased sensitivity, resolution, and speed. These new technologies are opening up new applications for flow cytometry in areas such as drug discovery and clinical research.
list all the companies in flow cytometry market
How much share, does the each segment holds, of the global Flow Cytometry Market?
How the end user segment is benefited by the emerging innovations in the Global Flow Cytometry Market?
How the North American region is expected to dominate the Global Flow Cytometry Market?